Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Anita, Laxova"'
Autor:
Yaoli, Yang, Trina, Hollatz, Zubin, Mukadam, Anita, Laxova, Catherine, Decker, Andrew T, Braun
Publikováno v:
In Journal of Cystic Fibrosis January 2021 20(1):127-132
Publikováno v:
International Journal of Neonatal Screening, Vol 8, Iss 4, p 54 (2022)
Our objective was to develop and test a new approach to obtaining parental policy guidance about disclosure of incidental findings of newborn screening for cystic fibrosis (CF), including heterozygote carrier status and the conditions known as CFTR-r
Externí odkaz:
https://doaj.org/article/f34de2f40c1444139e8e71d88cce39c9
Autor:
Andrew T. Braun, Christina B. Barreda, Ryan J. Coller, Jens C. Eickhoff, Philip M. Farrell, Anita Laxova, Michael J. Rock
Publikováno v:
J Cyst Fibros
BACKGROUND: The Wisconsin Cystic Fibrosis Neonatal Screening Project was a randomized clinical trial (RCT) revealing that children receiving an early diagnosis of CF via newborn screening (NBS) had improved nutritional outcomes but similar lung disea
Autor:
Elizabeth A. Worthey, Camille L. Birch, Anita Laxova, Brandon Wilk, Donna M. Brown, Philip M. Farrell, Melissa A. Wilk, James Holt, Nadiya Sosonkina, Andrew T. Braun
Publikováno v:
Cold Spring Harbor Molecular Case Studies
Variations in disease onset and/or severity have often been observed in siblings with cystic fibrosis (CF), despite the same CFTR genotype and environment. We postulated that genomic variation (modifier and/or pharmacogenomic variants) might explain
Autor:
Michael G. Rock, D. Stachiw-Hietpas, Pippa Simpson, Anita Laxova, Hara Levy, J. Biller, O. J. Lakser, Susanna A. McColley, Mei W. Baker, Samya Z. Nasr, Melodee Nugent, Mary K. Dahmer, Kaitlyn Schneck, Philip M. Farrell
Publikováno v:
Clinical Genetics. 89:539-549
Clinical heterogeneity in cystic fibrosis (CF) often causes diagnostic uncertainty in infants without symptoms and in older patients with milder phenotypes. We performed a cross-sectional evaluation of a comprehensive set of clinical and laboratory d
Autor:
Roger L. Brown, William M. Gershan, Adam J. Grieve, Anne Heun, Michael J. Rock, Audrey Tluczek, Philip M. Farrell, Anita Laxova
Publikováno v:
Journal of Cystic Fibrosis. 13:227-234
BackgroundLong-term psychosocial outcomes of cystic fibrosis (CF) patients diagnosed through newborn screening remain unknown.MethodsThis cross-sectional study compared three groups of youths (16 to 22years): CF patients diagnosed through NBS (CF-NBS
Autor:
Christopher G. Green, Anita Laxova, Michael J. Rock, Philip M. Farrell, William M. Gershan, Adam J. Grieve, Audrey Tluczek, Tara Becker
Publikováno v:
Journal of Developmental & Behavioral Pediatrics. 34:252-261
This study examined the convergent validity of health-related quality of life (HRQOL) reported by patients with cystic fibrosis compared with their parents' reports and objective pulmonary measures across 3 time points.Ninety-two children (8-13 years
Autor:
Philip M. Farrell, Audrey Tluczek, Anita Laxova, Craig A. Albers, Adam J. Grieve, Caroline N Racine-Gilles
Publikováno v:
Journal of School Health. 81:713-720
BACKGROUND: Cystic fibrosis (CF) is a chronic genetic disease that leads to the accumulation of thick mucus in multiple organ systems, leading to chronic lung infection and affecting the body's ability to absorb nutrients necessary for growth and dev
Autor:
Peter J. Mogayzel, Anita Laxova, Suzanne K. Cordovado, Marie C. Earley, Philip M. Farrell, W. Harry Hannon, Rena Driscoll-Dunn, Michael W. Konstan
Publikováno v:
Clinica Chimica Acta. 412:1376-1381
CDC's Newborn Screening Quality Assurance Program collaborated with several U.S. Cystic Fibrosis Care Centers to collect specimens for development of a molecular CFTR proficiency testing program using dried-blood spots for newborn screening laborator
Autor:
Ingrid Duguépéroux, Zhanhai Li, Virginie Scotet, Claude Férec, Gilles Rault, Philip M. Farrell, Aimee C. Walsh, Michel Roussey, Anita Laxova
Publikováno v:
Journal of Cystic Fibrosis. 9:44-50
BackgroundA comparison of the longitudinal progression of lung disease in cystic fibrosis patients identified through newborn screening (NBS) in cohorts located in two different countries has never been performed and was the primary objective of this